Capricor Therapeutics, Inc. · NASDAQ:CAPR

BlackRock, Inc. reported a 6.50% stake in Capricor Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2024 · Filed Feb 5, 2025

BlackRock, Inc. reported a 6.50% stake in Capricor Therapeutics, Inc., 2,966,914 shares, as a passive investor on Dec 31, 2024. Filed Feb 5, 2025 (Schedule 13G/A).

Stake
6.50%
Shares
2,966,914
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
BlackRock, Inc.6.50%2,966,914

Source

View original at SEC

Related